Biochemical and Biophysical Research Communications

Biochemical and Biophysical Research Communications, Vol.483, No.4 Entire volume, number list

ISSN: 0006-291X (Print)

In this Issue (26 articles)

979 - 980	Misery loves company - shared features of neurodegenerative disorders Bezprozvanny I, Sorgato MC, Carafoli E
981 - 987	Calcium's role as nuanced modulator of cellular physiology in the brain Frazier HN, Maimaiti S, Anderson KL, Brewer LD, Gant JC, Porter NM, Thibault O
988 - 997	Emerging pathways driving early synaptic pathology in Alzheimer's disease Briggs CA, Chakroborty S, Stutzmann GE
998 - 1004	Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity? Popugaeva E, Pchitskaya E, Bezprozvanny I
1005 - 1012	Astroglial calcium signalling in Alzheimer's disease Verkhratsky A, Rodriguez-Arellano JJ, Parpura V, Zorec R
1013 - 1019	Calcium and Parkinson's disease Surmeier DJ, Schumacker PT, Guzman JD, Ilijic E, Yang B, Zampese E
1020 - 1030	Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness Cieri D, Brini M, Cali T
1031 - 1039	Calcium in the pathomechanism of amyotrophic lateral sclerosis - Taking center stage? Patai R, Nogradi B, Engelhardt JI, Siklos L
1040 - 1050	Keeping Our Calcium in Balance to Maintain Our Balance Mark MD, Schwitalla JC, Groemmke M, Herlitze S
1051 - 1062	Striatal synaptic dysfunction and altered calcium regulation in Huntington disease Raymond LA
1063 - 1068	Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility Cherubini M, Gines S
1069 - 1077	Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases -Role of ER-mitochondria crosstalk Naia L, Ferreira IL, Ferreiro E, Rego AC
1078 - 1083	Possible role of mitochondrial permeability transition pore in the pathogenesis of Huntington disease Quintanilla RA, Tapia C, Perez MJ
1084 - 1095	Energy defects in Huntington's disease: Why "in vivo" evidence matters Liot G, Valette J, Pepin J, Flament J, Brouillet E
1096 - 1109	(Neuro)degenerated Mitochondria-ER contacts De Mario A, Quintana-Cabrera R, Martinvalet D, Giacomello M
1110 - 1115	Alpha-synuclein and beta-amyloid different targets, same players: calcium, free radicals and mitochondria in the mechanism of neurodegeneration Angelova PR, Abramov AY
1116 - 1124	The plasma membrane calcium pumps: focus on the role in (neuro) pathology Brini M, Carafoli E, Cali T
1125 - 1136	Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins Erana H, Venegas V, Moreno J, Castilla J
1137 - 1142	Amyloid-beta and tau pathology following repetitive mild traumatic brain injury Edwards G, Moreno-Gonzalez I, Soto C
1143 - 1147	Cellular prion protein as a receptor for amyloid-beta oligomers in Alzheimer's disease Salazar SV, Strittmatter SM
1148 - 1155	Almost a century of prion protein(s): From pathology to physiology, and back to pathology Peggion C, Bertoli A, Sorgato MC
1156 - 1165	A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease Reddy PH, Tonic S, Kumar S, Vijayan M, Kandimalla R, Kuruva CS, Reddy AP
1166 - 1177	Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders Agarwal S, Yadav A, Chaturvedi RK
1178 - 1186	The role of extracellular vesicles in neurodegenerative diseases Quek C, Hill AF
1187 - 1193	Pathways to mitochondrial dysfunction in ALS pathogenesis Carri MT, D'Ambrosi N, Cozzolino M
1194 - 1205	Tetrahydrocarbazoles decrease elevated SOCE in medium spiny neurons from transgenic YAC128 mice, a model of Huntington's disease Czeredys M, Maciag F, Methner A, Kuznicki J